Form 4: Alphatec EVP Sells $679K in Stock Under 10b5-1 Plan
Insider Transaction Report
Alphatec Holdings, Inc.'s EVP of People & Culture, Craig E. Hunsaker, sold 32,584 shares of common stock for approximately $679,000 under a pre-arranged trading plan.
Summary
- Craig E. Hunsaker, Executive Vice President of People & Culture at Alphatec Holdings, Inc. (ATEC), disposed of 32,584 shares of common stock.
- The transaction occurred on December 10, 2025, at a price of $20.84 per share.
- The total value of the shares sold amounts to approximately $679,000.
- Following this transaction, Mr. Hunsaker beneficially owns 1,256,558 shares of Alphatec Holdings, Inc. common stock.
- The sale was executed pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
Sentiment
Score: 4
Explanation: While the sale was executed under a Rule 10b5-1 plan, indicating it was pre-scheduled and not necessarily a reaction to new negative information, it still represents a reduction in direct insider ownership, which can be perceived as a neutral to slightly negative signal by the market.
Negatives
- The sale of 32,584 shares by a key executive, even under a pre-arranged plan, reduces their direct financial alignment with the company's future stock price appreciation.
Risks
- Potential for negative market perception due to insider selling, despite the transaction being executed under a Rule 10b5-1 plan.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This insider transaction is specific to Alphatec Holdings, Inc. and does not provide direct insights into broader industry trends. However, insider activity is often monitored by investors as a signal of management's confidence in the company's prospects within its competitive medical device and spine surgery market.
Stakeholder Impact
- Shareholders: May interpret the insider sale as a signal, potentially influencing their investment decisions, though the 10b5-1 plan mitigates immediate concerns about new negative information.
- Employees: No direct impact mentioned, but executive stock sales can sometimes be a topic of internal discussion.
Key Dates
| Date | Description |
|---|---|
| 12/10/2025 | Date of transaction where 32,584 shares of common stock were sold. |
| 12/12/2025 | Date the Form 4 filing was signed by the attorney-in-fact. |
Recommendation
holdThe sale by the EVP of People & Culture was conducted under a Rule 10b5-1 plan, suggesting it was a pre-scheduled transaction rather than a reaction to immediate company news. While it reduces insider ownership, this single transaction, without further context on the company's performance or other insider activity, does not warrant a strong 'sell' recommendation. Investors should 'hold' and monitor future filings and company performance for more comprehensive insights.
Keywords
Alphatec Holdings, ATEC, Insider Sale, Form 4, Craig E. Hunsaker, Executive Compensation, Stock Transaction, 10b5-1 Plan, Medical Devices, Spine Surgery
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.